Submission: April 28, 2017; Published: July 03, 2017
*Corresponding author: Pratyay Hasan, Indoor Medical Officer, Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh, Email: email@example.com
How to cite this article: Hasan P, Mozazfia KT, Saleh MAD, Hasan D. A Systematic Analysis of Literary Case Reports of Protein S Deficiency Implicated in Pathogenesis of Arterial Thrombosis. J Cardiol & Cardiovasc Ther 2017; 6(2): 555685. DOI: 10.19080/JOCCT.2017.06.555685
Introduction and background: Protein S is a vitamin K dependent natural anticoagulant. Deficiency of protein S is long known to cause venous thrombosis but not arterial thrombosis. Instances of arterial thrombosis due to protein S deficiency are very rare. So, very little can be known about the phenomenon, which is why this study attempts to elucidate on the patients who have suffered from the disease process.
Method: 24 articles describing 27 cases where arterial thrombosis occurred along with protein S deficiency were included and results from the reported cases were collated together then analyzed thoroughly.
Results: The minimum age was 4 and the maximum age was 64, where the mean age was 37.07 (±16.88 SD) year, median age being 37 year Cerebral arteries and peripheral arteries are the most commonly involved circulations (each constitute 29.63% of cases), making the coronary circulation the second most commonly involved region (14.81%). The mean activity of protein S was 26 (±5 SE)%, mean total protein S level was 52 (±10 SE)%, mean free protein S level was 37.3 (±6.8 SE)%, activity of protein C was 80 (±15 SE)%, mean total protein C level was 74 (±11 SE)%, mean anti-thrombin III level was 69 (±6 SE)%.
Conclusion: Many circulations and regions in the body can be affected, most common being cerebral and peripheral, followed by coronary circulation. In the absence of standardized measurement and assay techniques of different forms of protein S, comparing and collating results is extremely difficult. A standard should be set up. And further larger studies should be undertaken to determine the true contribution of deficient protein S level in pathogenesis of arterial thrombosis. Especially the researcher in hematology, cardiology and neurology should work together to determine the true significance of protein S.
Keywords: Case series; Systematic analysis; Protein S; Arterial thrombosis; Cerebral infarct; Coronary infarct; Hematology; Cardiology; Neurology
Protein S, a vitamin K dependent plasma glycoprotein was discovered in 1977 by Di Scipio et al.  in the city of Seattle, after which it was named [1,2]. The anticoagulant property of Protein S has been discovered by Walker et al. Hereditary deficiency of protein S has been long known for causing venous thrombosis but the effect of the deficiency in pathogenesis of arterial thrombosis is much less acknowledged [4,5]. It is because, thrombophilia is usually associated with venous, rather than arterial thrombosis. Since the first case of venous thromboembolism reported , it is known that a deficiency of protein S predisposes subjects to recurrent venous thromboembolism (VTE) and fetal loss .But with advancement of time, accumulation of reported cases has raised the concern that arterial thrombosis can also occur due to protein S deficiency. Girolami et al.  have reported that both venous and arterial thrombosis may occur in any given patient with a thrombophilic state. Protein S deficiency has been reported as a suspected cause for arterial thrombosis in people under the age of 45 years . Deficiency of any one of the Protein C, Protein S or Antithrombin III may predispose to in-situ thrombosis within either the arterial or venous system and are a cause of otherwise unexplained strokes in young patients . Carod-Artal et al.  found that prothrombotic conditions are more frequent among the young ischaemic stroke patients classified as strokes of undetermined cause. Dykes et al.  have determined the prevalence of protein S deficiency to be between 0.03 and 0.13% in general population in a study involving 3788 Scottish volunteers. The estimated prevalence in the general Japanese population is 1-2% . But there is much scarcity of available literature documenting arterial thrombosis caused by protein S deficiency, which prompted this current study.
A systemic search was conducted on 18th May 2016, in the electronic database "PubMed",www.ncbi.nlm.nih.gov/pubmed,using keywords, such as, "protein s", "case reports", "arterial", and "thrombosis". The exact search phrase is mentioned here: («protein s»[MeSH Terms] OR «protein s»[All Fields]) AND («case reports»[Publication Type] OR «case reports»[All Fields]) AND («arteries»[MeSH Terms] OR «arteries»[All Fields] OR «arterial»[All Fields]) AND («thrombosis»[MeSH Terms] OR «thrombosis»[All Fields]).
The search resulted with findings of total 94 articles, but again the search was refined with filters "case reports", and only articles with full text availability were sought, and ultimately 55 articles were found. Out of these, full texts of eight articles were not found, despite all efforts. Out of these eight case reports, three were in different language, so five remained, out of them, one was about venous thrombosis, one was about unrelated topic, so remained only four articles that were not found in total. Two personal case reports were also added, making the number of total available articles to 49 .
But after thorough perusal of all the 49 articles, 25 articles were excluded. Out of these 25 articles, three were written in languages other than English, five mentioned venous thrombosis, four described anti-phospholipid antibody syndrome, one described anti-thrombin III deficiency, four mentioned isolated protein c deficiency, one mentioned factor V Leiden mutation, one mentioned beta-2-glycoprotein related arterial thrombosis, one was a comment on already included case report, and two were reviews, etc. only a total of 24 case reports were found that met the inclusion criteria. At last the analysis was conducted with these 24 articles [13-36]. These 24 articles described 27 cases where arterial thrombosis occurred along with protein S deficiency. The articles and the results are summarized in Table 1. The process is shown in Figure 1 [37,38]. For analysis of the studies, SPSS (Statistical Package for Social Science), version 23 (IBM Corporation) was used.
Summary of the cases and findings are shown in Table 1.
In this study a total of 27 cases are included, among them 13 are male (51.85%) and 14 are female (48.15%), as shown in Figure 2.
The minimum age was 4 and the maximum age was 64, where the mean age was 37.07 (±16.88 SD) year, median age being 37 year (Figure 3 & 4) and (Table 2).
The arterial circulation involved are shown in Figure 5, demonstrating the fact that cerebral arteries and peripheral arteries are the most common circulations (each constitute 29.63% of cases), making the coronary circulation the second most commonly involved region (14.81%). Figure 6 demonstrates the percentages of involved areas, grouped by sex. Cerebral circulation was most commonly involved in females (22.22%) and peripheral circulation was most commonly involved in male (22.22%).
Among the 27, three cases (10%) were fatal. The different measurements of protein S, protein C, and anti-thrombin III are shown in Table 3 and the same measurements according to sex distribution are shown in Table 4.
In Table 5 and Figure 7 associated changes in protein C and anti-thrombin III levels are shown. Although in some patients, protein C levels are not reported (5 cases, 18.52%), but in most of the patients, protein C level was decreased (37.04%). There is a rather interesting rise in protein C level in 11.11% of cases.
From the accumulated results, it can be seen that there is not much difference in distribution of sex of the cases. The age distribution is also a similar tale, as it can happen in very early years (4 years) to very late years (64 years), in both sex groups (Figure 4) and (Table 2).
The arterial circulation involved are shown in Figure 5, demonstrating the fact that cerebral arteries and peripheral arteries are the most common circulations (each constitute 29.63% of cases), making the coronary circulation the second most commonly involved region (14.81%). Figure 5 demonstrates the percentages of involved areas, grouped by sex. Cerebral circulation was most commonly involved in females (22.22%) and peripheral circulation was most commonly involved in male (22.22%). This phenomenon should be investigated further in large studies. The result shows that not only cerebral circulation, peripheral circulation and coronary circulation are also potentially at risk of arterial thrombosis in case of protein S deficiency. Maybe the effect and distribution of measurements of protein S levels should be investigated in cases of myocardial infarctions, especially, if traditional risk factors are absent and uncommon causes are sought.
In the included case reports, protein S are measured in various forms, total antigen, free antigen (unbound) and functional activity and also, there are substantial amount of variability in expressing the results [13-36]. The cause behind this is there are two forms of protein S in plasma, a free form and a complex form. The free form of protein S is active. The bound form comprises 65% of the total protein S, and it is complexed to C4b-binding protein (C4bBP) and is inactive. The availability of C4bBP regulates the proportion of the free and bound forms of protein S. Due to this variability in the forms of protein S in plasma, at least three types of hereditary Protein S deficiency mentioned in available literature: 
Type I (quantitative defect): In this classic type of protein S deficiency, all antigenic type of protein S level (total, free and bound) are decreased and so is the functional activity level. [6,39,40].
Type II (qualitative defect): In this type of deficiency, all antigen levels of protein S are normal but functional activity is decreased.
Type III or Type IIa: In this type of deficiency, only free protein S level is decreased, and bound protein S level is increased, total amount of protein S remains unaltered and within normal limit. Functional activity is decreased.
So, protein S functional activity is decreased in all types. It can be seen that type II deficiencies are not detected by free protein S antigen assays, and type II and type III deficiencies are not detected by total protein S antigen assays . It is shown that some total protein S assay results could be normal even in the presence of a type I deficiency.
There are two types of assays that test for protein S deficiency:
Functional (activity) assays.
Antigenic (quantitative immunologic) assays.
In the included studies, the authors have used different reference values. Actually protein S should be measured against age specific reference values. Dykes et al.  have proposed such reference values. In general, levels of total or free protein S antigen <60 to 65IU/dL are considered to be in the deficient range . Although almost every study included has reported their values in percentages, and the detailed is not known about any standard against which the percentage was determined. In the included studies not only the activity level but also the antigen level was also expressed in percentages. In a population study involving 3788 healthy Scottish volunteers, Dykes et al.  used 100% to denote the antigen present in 1ml of normal blood plasma derived from a group of 14 men and 11 women with age ranging between 21-62 years. Similar standards are used in different laboratories, but the detail of the standard are often unavailable to the clinicians, and so often absent in the reported case. But to analyze and accumulate the results together it was imperative that all results must be expressed in uniform measurement standards. Using international units could be a better alternative and could make comparison and collection of results a lot easier. In the current study, original values as reported by the authors of the case reports are retained.
Due to such variability in the forms of both protein S and protein C, reporting of the levels of protein S and protein C is a very much difficult task, as Marlar & Gausman  have rightly described as "nightmare". In the included studies also, proof in favor of this statement is seen. Many have reported various combinations of measurements of activity level, total antigenic level, free antigenic levels of protein S and protein C. Some have reported antithrombin III level as well.
Protein S deficiency can also be acquired due to 
Vitamin K-antagonist therapy.
Various disorders, such as
Disseminated intravascular coagulation and
Chronic infections (e.g. HIV).
In many case reports included in this study, co-existent protein C deficiency is also reported. Heterozygous deficiency of protein C may be of two types, based on immunologic and functional assays:
a) Type 1 deficiency: Protein C concentration is approximately 50% of normal in both immunologic and functional assays . Most genetic protein C mutations result in Type 1 deficiency .
b) Type 2 deficiency: Normal plasma protein C antigen levels with decreased functional activity [45,46]. This type constitutes for 15% of symptomatic deficiencies [47,48].
To detect these two types of protein C defects, two types of tests are employed, which are:
1. Immunologic: Antigen level is measured using any one of the following :
There is not much interesting information in age and sex distribution of protein S deficient patients who presented with arterial thrombosis. Many circulations and regions in the body can be affected, most common being cerebral and peripheral, followed by coronary circulation. In the absence of standardized measurement and assay techniques of different forms of protein S, comparing and collating results is extremely difficult. A standard should be set up. And further larger studies should be undertaken to determine the true contribution of deficient protein S level in pathogenesis of arterial thrombosis. Especially the researcher in hematology, cardiology and neurology should work together to determine the true significance of protein S.